-
J&J cell therapy gains edge over Bristol Myers rival
Jonathan Raa | Nurphoto | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Hi folks! Two competing cell therapies from Bristol Myers Squibb…
-
Big pharma Merck, Bristol Myers, J&J prepare to lose revenue
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSE Big pharmaceutical companies such as Bristol Myers Squibb, Merck and Johnson & Johnson face a looming threat that will put…
-
Investor Michael Farr is back with his top 10 stocks he’s buying for 2024, and the tilt is defensive
Traders work on the floor of the New York Stock Exchange (NYSE) on the first day back since the Christmas holiday on December 26, 2023 in New York City. Spencer Platt | Getty Images News…
-
Novavax vaccine clears key step on path to FDA authorization
Novavax’s two-dose Covid-19 vaccine for adults ages 18 and older cleared a key step on the path toward Food and Drug Administration authorization on Tuesday. The FDA’s committee of independent vaccine experts voted 21 to…
-
I like Lam Research over Taiwan Semiconductor
Monolithic Power Systems Inc: “It sells at 40 times earnings, and you know I’m not recommending stocks unless they have a reasonable multiple.” Disclosure: Cramer’s Charitable Trust owns shares of Chevron. VIDEO4:0604:06 Cramer’s lightning round:…
-
Pfizer asks FDA to authorize Covid booster shots for all adults
Germaine T. Leftwich, 67, receives a Pfizer covid-19 vaccine booster shot from Dr. Tiffany Taliaferro at the Safeway on Capitol Hill in Washington, D.C., on Monday, October 4, 2021. Tom Williams | CQ-Roll Call, Inc.…
-
J&J Covid vaccine recipients are better off getting Pfizer or Moderna booster, NIH study suggests
Pfizer-BioNTech Covid-19 vaccines at a senior living facility in Worcester, Pennsylvania, U.S., on Wednesday, Aug. 25, 2021. Hannah Beier | Bloomberg | Getty Images Johnson & Johnson Covid-19 vaccine recipients are better off getting a…
-
U.S. moves closer to clearing Moderna and J&J Covid booster shots this week
Millions of Americans will be one step closer to receiving a Covid-19 booster shot this week when a key Food and Drug Administration advisory panel meets Thursday and Friday to debate extra doses of the…
-
Fauci defends FDA panel decision to reject third doses for all Americans
Top infectious disease expert Dr. Anthony Fauci responds to accusations by Sen. Rand Paul (R-KY) as he testifies before the Senate Health, Education, Labor, and Pensions Committee on Capitol hill in Washington, D.C., July 20,…
-
U.S. to begin wide distribution of third vaccine doses next month
The United States will begin widely distributing Covid-19 booster shots next month as new data shows that vaccine protection wanes over time, top U.S. health officials announced Wednesday. It’s now “very clear” that immunity starts…
Latest Posts
- U.S. economy will see ‘more things break’ in 2025 if rates stay high: Strategist
- Asia FX weakens as M.East tensions, rate fears put dollar at over 5-mth high By Investing.com
- Lost Treasure Found? Bitcoin Miner Transfers Over $3 Million BTC After 14-Year Dormancy – NewsBTC
- Boeing defends 787 Dreamliner safety after whistleblower claims
- S&P 500 and Nasdaq close 1% lower as yields jump, traders await Israel response to Iran: Live updates – CNBC
